Loading clinical trials...
Loading clinical trials...
Human papillomavirus(HPV) infect epithelial cells and have the capacity to stimulate cell abnormal hyperplasia, especially by those high-risk HPV types. HPV vaccine primarily targeting HPV6/11/16/18 h...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
First Hospital of China Medical University
NCT07211204 · Atypical Squamous Cell of Undetermined Significance, ASC-US, and more
NCT06823817 · Cervical Cancers, Cervical Intraepithelial Neoplasia (CIN)
NCT06700941 · Cervical Intraepithelial Neoplasia (CIN), Genital Warts, and more
NCT06665841 · Cervical Intraepithelial Neoplasia (CIN), Cervical Cancer, and more
the First Hospital of China Medical University
Shenyang, Liaoning
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions